Bio-Technology General Euflexxa 1% Sodium Hyaluronate

Země: Singapur

Jazyk: angličtina

Zdroj: HSA (Health Sciences Authority)

Dostupné s:

FERRING PHARMACEUTICALS PRIVATE LIMITED

Třída:

Class D medical device

Výrobce:

Bio-Technology General (Israel) Ltd.

Terapeutické oblasti:

Orthopaedics

Terapeutické indikace:

EUFLEXXA is indicated for the treatment of pain caused by osteoarthritis of the knee, hip, temporomandibular, carpometacarpal, shoulder and ankle joints. EUFLEXXA aids in lubrication of the joint, allows for greater mobility and flexibility of the treated joint, and reduces pain in the affected joint.

Přehled produktů:

Device System Info:[Sterile Medical Device], EUFLEXXA is packed in a single-use, aseptically-filled disposable sterile 2.25 ml syringe (nominal volume) containing either 1 ml or 2 ml of 1% microbial fermentation-derived NaHA in phosphate-buffered saline; Models: Euflexxa 1% Sodium Hyaluronate - 3 x 2ml, Euflexxa 1% Sodium Hyaluronate - 1 x 2ml

Datum autorizace:

2017-04-28